Ariceum Therapeutics logo

Ariceum Therapeutics

ID: 13000460

Ariceum Therapeutics is developing novel drugs for systemic targeted radiation therapy.

3

Funding Rounds

$78.1m

Money raised

Overview

Ariceum Therapeutics is developing novel drugs for systemic targeted radiation therapy.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Ariceum Therapeutics has raised a total of $78.1m in funding over 3 rounds.

Key Insights:

  • Ariceum Therapeutics April 2023 Series A Funding Round: $25m
  • Ariceum Therapeutics Series A round, June 2022: $26.1m
  • Ariceum Therapeutics June 2022 Series A Funding Round: $27m

Industries

Ariceum Therapeutics is active in the following industries: